540 related articles for article (PubMed ID: 25260581)
21. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
Buncharoen W; Saenphet K; Saenphet S; Thitaram C
J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
[TBL] [Abstract][Full Text] [Related]
22. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
23. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
24. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.
Peng Y; Peng C; Wu Y; Sun C; Li X
BMC Complement Med Ther; 2021 Oct; 21(1):272. PubMed ID: 34715848
[TBL] [Abstract][Full Text] [Related]
25. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
26. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats.
Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659
[TBL] [Abstract][Full Text] [Related]
27. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S
Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant and anti-inflammatory activities of aqueous extract of Centipeda minima.
Huang SS; Chiu CS; Lin TH; Lee MM; Lee CY; Chang SJ; Hou WC; Huang GJ; Deng JS
J Ethnopharmacol; 2013 May; 147(2):395-405. PubMed ID: 23506988
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract][Full Text] [Related]
30. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model.
Afriyie DK; Asare GA; Bugyei K; Adjei S; Lin JM; Peng J; Hong ZF
J Ethnopharmacol; 2014 Nov; 157():90-8. PubMed ID: 25256687
[TBL] [Abstract][Full Text] [Related]
31. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
32. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach.
Rasheed RA; Sadek AS; Khattab RT; Elkhamisy FAA; Abdelfattah HA; Elshaer MMA; Almutairi SM; Hussein DS; Embaby AS; Almoatasem MAM
PLoS One; 2023; 18(11):e0293682. PubMed ID: 37943844
[TBL] [Abstract][Full Text] [Related]
33. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
[TBL] [Abstract][Full Text] [Related]
34. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ
Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617
[TBL] [Abstract][Full Text] [Related]
35. Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.
Jin BR; Kim HJ; Park SK; Kim MS; Lee KH; Yoon IJ; An HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30322186
[TBL] [Abstract][Full Text] [Related]
36. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
[TBL] [Abstract][Full Text] [Related]
37. Anti-proliferation effects of Cistanches salsa on the progression of benign prostatic hyperplasia.
Jeon HJ; Chung KS; An HJ
Can J Physiol Pharmacol; 2016 Jan; 94(1):104-11. PubMed ID: 27123496
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.
Chen J; Zhang HF; Xiong CM; Ruan JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):806-810. PubMed ID: 27924509
[TBL] [Abstract][Full Text] [Related]
39. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats.
Shabani E; Kalantari H; Kalantar M; Goudarzi M; Mansouri E; Kalantar H
BMC Complement Med Ther; 2021 Dec; 21(1):301. PubMed ID: 34930229
[TBL] [Abstract][Full Text] [Related]
40. The mechanism of hepatoprotective effect of sesquiterpene rich fraction from Cichorum glandulosum Boiss. et Huet on immune reaction-induced liver injury in mice.
Xin X; Yang W; Yasen M; Zhao H; Aisa Ha
J Ethnopharmacol; 2014 Sep; 155(2):1068-75. PubMed ID: 24933227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
